Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 4, 2011, Pages 587-597

  Midde, Narasimha M ^a   Gomez, Adrian M ^a   Harrod, Steven B ^a   Zhu, Jun ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CREB; Dopamine; ERK; HIV 1 viral protein; Locomotion; Nicotine; Phosphorylation; Prefrontal cortex; Sensitization; Transgenic rat

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; HABITUATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LIMBIC CORTEX; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSGENIC RAT; VENTRAL TEGMENTUM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HABITUATION, PSYCHOPHYSIOLOGIC; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MODELS, ANIMAL; MOTOR ACTIVITY; NICOTINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; SMOKING; VENTRAL TEGMENTAL AREA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; NICOTIANA TABACUM; RATTUS;

EID: 79953709418     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.03.013     Document Type: Article

References (101)

1. N.A. Addy, E.F. Fornasiero, T.R. Stevens, J.R. Taylor, and M.R. Picciotto Role of calcineurin in nicotine-mediated locomotor sensitization J Neurosci 27 2007 8571 8580 (Pubitemid 47254265)
2. S.G. Anagnostaras, and T.E. Robinson Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning Behav Neurosci 110 1996 1397 1414 (Pubitemid 27009202)
3. J.R. Berger, and G. Arendt HIV dementia: the role of the basal ganglia and dopaminergic systems J Psychopharmacol 14 2000 214 221
4. M.T. Berhow, N. Hiroi, and E.J. Nestler Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine J Neurosci 16 1996 4707 4715 (Pubitemid 26251066)
5. K.C. Berridge The debate over dopamine's role in reward: the case for incentive salience Psychopharmacol Berl 191 2007 391 431 (Pubitemid 46355895)
6. K.C. Berridge, and T.E. Robinson What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28 1998 309 369 (Pubitemid 29012677)
7. R.A. Bevins, and M.I. Palmatier Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect Behav Brain Res 143 2003 65 74 (Pubitemid 36802185)
8. D.H. Brunzell, D.S. Russell, and M.R. Picciotto In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice J Neurochem 84 2003 1431 1441 (Pubitemid 36343609)
9. D.H. Brunzell, Y.S. Mineur, R.L. Neve, and M.R. Picciotto Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference Neuropsychopharmacology 34 2009 1993 2001
10. J.E. Burkhalter, C.M. Springer, R. Chhabra, J.S. Ostroff, and B.D. Rapkin Tobacco use and readiness to quit smoking in low-income HIV-infected persons Nicotine Tob Res 7 2005 511 522 (Pubitemid 41600909)
11. D.N. Burns, D. Hillman, J.D. Neaton, R. Sherer, T. Mitchell, and L. Capps Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS J Acquir Immune Defic Syndr Hum Retrovirol 13 1996 374 383 (Pubitemid 26404532)
12. W.A. Carlezon Jr., J. Thome, V.G. Olson, S.B. Lane-Ladd, E.S. Brodkin, and N. Hiroi Regulation of cocaine reward by CREB Science 282 1998 2272 2275 (Pubitemid 29004079)
13. W.A. Cass, M.E. Harned, L.E. Peters, A. Nath, and W.F. Maragos HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat Brain Res 984 2003 133 142 (Pubitemid 36976802)
14. CDC Cigarette smoking among adults - United States, 2006 Morbidity and Mortality Weekly Report 56 44 2007 1157 1161
15. L. Chang, G.J. Wang, N.D. Volkow, T. Ernst, F. Telang, and J. Logan Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse Neuroimage 42 2008 869 878
16. L. Chen, and M. Xu Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking J Neurochem 114 2010 530 541
17. P.B. Clarke, and R. Kumar Characterization of the locomotor stimulant action of nicotine in tolerant rats Br J Pharmacol 80 1983 587 594 (Pubitemid 14205931)
18. P.B. Clarke, and R. Kumar The effects of nicotine on locomotor activity in non-tolerant and tolerant rats Br J Pharmacol 78 1983 329 337 (Pubitemid 13192204)
19. W.A. Corrigall, K.B. Franklin, K.M. Coen, and P.B. Clarke The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine Psychopharmacol Berl 107 1992 285 289
20. W.A. Corrigall, K.M. Coen, and K.L. Adamson Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area Brain Res 653 1994 278 284 (Pubitemid 24252850)
21. K. Crothers, T.A. Griffith, K.A. McGinnis, M.C. Rodriguez-Barradas, D.A. Leaf, and S. Weissman The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans J Gen Intern Med 20 2005 1142 1145 (Pubitemid 43110266)
22. S. Davis, P. Vanhoutte, C. Pages, J. Caboche, and S. Laroche The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo J Neurosci 20 2000 4563 4572 (Pubitemid 30396622)
23. L. Del Valle, S. Croul, S. Morgello, S. Amini, J. Rappaport, and K. Khalili Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy J Neurovirol 6 2000 221 228 (Pubitemid 30447166)
24. D.P. DiRocco, Z.S. Scheiner, C.B. Sindreu, G.C. Chan, and D.R. Storm A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitization J Neurosci 29 2009 2393 2403
25. M.J. Duncan, A.J. Bruce-Keller, C. Conner, P.E. Knapp, R. Xu, and A. Nath Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine Am J Physiol Regul Integr Comp Physiol 295 2008 R1680 R1687
26. M.B. El-Ghundi, T. Fan, J.M. Karasinska, J. Yeung, M. Zhou, and B.F. O'Dowd Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice Psychopharmacol Berl 207 2010 599 618
27. B.J. Everitt, and T.W. Robbins Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat Neurosci 8 2005 1481 1489 (Pubitemid 41573659)
28. M.J. Ferris, C.F. Mactutus, and R.M. Booze Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Neurosci Biobehav Rev 32 2008 883 909
29. J.S. Fink, and G.P. Smith Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats Neurosci Lett 17 1980 61 65 (Pubitemid 10075326)
30. S. Fitting, R.M. Booze, U. Hasselrot, and C.F. Mactutus Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study Hippocampus 18 2008 135 147 (Pubitemid 351413481)
31. A.S. Furber, R. Maheswaran, J.N. Newell, and C. Carroll Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review Sex Transm Infect 83 2007 41 46 (Pubitemid 46293804)
32. M. Fuster, V. Estrada, M.C. Fernandez-Pinilla, M.E. Fuentes-Ferrer, M.J. Tellez, and J. Vergas Smoking cessation in HIV patients: rate of success and associated factors HIV Med 10 2009 614 619
33. J.A. Girault, E. Valjent, J. Caboche, and D. Herve ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol 7 2007 77 85 (Pubitemid 46238037)
34. E.R. Gritz, D.J. Vidrine, A.B. Lazev, B.C. Amick 3rd, and R.C. Arduino Smoking behavior in a low-income multiethnic HIV/AIDS population Nicotine Tob Res 6 2004 71 77 (Pubitemid 38372476)
35. S.B. Harrod, and M.L. Van Horn Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats Pharmacol Biochem Behav 94 2009 296 304
36. S.B. Harrod, C.F. Mactutus, K. Bennett, U. Hasselrot, G. Wu, and M. Welch Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors Pharmacol Biochem Behav 78 2004 581 592 (Pubitemid 38901025)
37. S.B. Harrod, C.F. Mactutus, S. Fitting, U. Hasselrot, and R.M. Booze Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine Pharmacol Biochem Behav 90 2008 723 729
38. S.L. Hershberger, D.G. Fisher, G.L. Reynolds, J.A. Klahn, and M.M. Wood Nicotine dependence and HIV risk behaviors among illicit drug users Addict Behav 29 2004 623 625 (Pubitemid 38410843)
39. M. Hetman, and A. Gozdz Role of extracellular signal regulated kinases 1 and 2 in neuronal survival Eur J Biochem 271 2004 2050 2055 (Pubitemid 38747973)
40. L.G. Hudson, J.M. Gale, R.S. Padilla, G. Pickett, B.E. Alexander, and J. Wang Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes Mol Carcinog 49 2010 619 629
41. S.D. Iniguez, B.L. Warren, R.L. Neve, S.J. Russo, E.J. Nestler, and C.A. Bolanos-Guzman Viral-mediated expression of extracellular signal-regulated kinase-2 in the ventral tegmental area modulates behavioral responses to cocaine Behav Brain Res 214 2010 460 464
42. E.T. Iwamoto An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods Psychopharmacol Berl 84 1984 374 382 (Pubitemid 15205964)
43. K.J. Jackson, J.M. McIntosh, D.H. Brunzell, S.S. Sanjakdar, and M.I. Damaj The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal J Pharmacol Exp Ther 331 2009 547 554
44. A. Jerome, and P.R. Sanberg The effects of nicotine on locomotor behavior in non-tolerant rats: a multivariate assessment Psychopharmacol Berl 93 1987 397 400 (Pubitemid 17160668)
45. E.M. Joyce, and G.F. Koob Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system Psychopharmacol Berl 73 1981 311 313 (Pubitemid 11114112)
46. P.W. Kalivas Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants Drug Alcohol Depend 37 1995 95 100
47. M.D. Kass, X. Liu, M. Vigorito, L. Chang, and S.L. Chang Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats J Neuroimmune Pharmacol 5 2010 566 573
48. P.H. Kelly, and S.D. Iversen Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur J Pharmacol 40 1976 45 56
49. B.O. Kim, Y. Liu, Y. Ruan, Z.C. Xu, L. Schantz, and J.J. He Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline Am J Pathol 162 2003 1693 1707 (Pubitemid 36512853)
50. T. Kita, M. Okamoto, and T. Nakashima Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats Life Sci 50 1992 583 590
51. G.F. Koob, L. Stinus, and M. Le Moal Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system Behav Brain Res 3 1981 341 359 (Pubitemid 11020299)
52. E. Koutsilieri, S. Sopper, C. Scheller, V. ter Meulen, and P. Riederer Involvement of dopamine in the progression of AIDS Dementia Complex J Neural Transm 109 2002 399 410 (Pubitemid 34251642)
53. C. Ksir Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis Psychopharmacol Berl 115 1994 105 109 (Pubitemid 24207768)
54. K.L. Kubos, T.H. Moran, and R.G. Robinson Differential and asymmetrical behavioral effects of electrolytic or 6-hydroxydopamine lesions in the nucleus accumbens Brain Res 401 1987 147 151 (Pubitemid 17234399)
55. A.M. Kumar, J.B. Fernandez, E.J. Singer, D. Commins, D. Waldrop-Valverde, and R.L. Ownby Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains J Neurovirol 15 2009 257 274
56. S.R. Laviolette, and D. van der Kooy The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour Nat Rev Neurosci 5 2004 55 65 (Pubitemid 38076184)
57. X. Liu, L. Chang, M. Vigorito, M. Kass, H. Li, and S.L. Chang Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat J Neuroimmune Pharmacol 4 2009 309 316
58. A.C. Lloyd Distinct functions for ERKs? J Biol 5 2006 13
59. M. Louis, and P.B. Clarke Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats Neuropharmacology 37 1998 1503 1513 (Pubitemid 28550424)
60. L. Lu, X. Wang, P. Wu, C. Xu, M. Zhao, and M. Morales Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving Biol Psychiatry 66 2009 137 145
61. V.K. Manda, R.K. Mittapalli, W.J. Geldenhuys, and P.R. Lockman Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity J Neurochem 115 2010 515 525
62. H.D. Mansvelder, J.R. Keath, and D.S. McGehee Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas Neuron 33 2002 905 919 (Pubitemid 34246356)
63. W.F. Maragos, K.L. Young, J.T. Turchan, M. Guseva, J.R. Pauly, and A. Nath Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function J Neurochem 83 2002 955 963 (Pubitemid 35316046)
64. Y.S. Mineur, D.H. Brunzell, S.R. Grady, J.M. Lindstrom, J.M. McIntosh, and M.J. Marks Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning Genes Brain Behav 8 2009 257 266
65. S. Nahvi, and N.A. Cooperman Review: the need for smoking cessation among HIV-positive smokers AIDS Educ Prev 21 2009 14 27
66. H. Nakayama, T. Numakawa, T. Ikeuchi, and H. Hatanaka Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells J Neurochem 79 2001 489 498 (Pubitemid 33029922)
67. A. Nath Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction Ann NY Acad Sci 1187 2010 122 128
68. A. Nath, J. Jankovic, and L.C. Pettigrew Movement disorders and AIDS Neurology 37 1987 37 41 (Pubitemid 17230105)
69. E.J. Nestler Molecular neurobiology of addiction Am J Addict 10 2001 201 217 (Pubitemid 32879087)
70. R. Niaura, W.G. Shadel, K. Morrow, K. Tashima, T. Flanigan, and D.B. Abrams Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now Clin Infect Dis 31 2000 808 812 (Pubitemid 32295508)
71. R.B. Nieman, J. Fleming, R.J. Coker, J.R. Harris, and D.M. Mitchell The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals AIDS 7 1993 705 710 (Pubitemid 23204965)
72. M. Nisell, G.G. Nomikos, and T.H. Svensson Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release Pharmacol Toxicol 75 1994 348 352 (Pubitemid 24366267)
73. M. Nisell, G.G. Nomikos, and T.H. Svensson Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area Synapse 16 1994 36 44 (Pubitemid 24013237)
74. L.R. Norman, M. Basso, A. Kumar, and R. Malow Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research Curr Drug Abuse Rev 2 2009 143 156
75. M. Obermann, M. Kuper, O. Kastrup, O. Yaldizli, S. Esser, and J. Thiermann Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV J Neurol 256 2009 948 953
76. F.J. Palella Jr., R.K. Baker, A.C. Moorman, J.S. Chmiel, K.C. Wood, and J.T. Brooks Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 2006 27 34 (Pubitemid 44306484)
77. G. Panagis, and C. Spyraki Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation Psychopharmacol Berl 123 1996 280 288 (Pubitemid 26074234)
78. S.C. Pandey, A. Roy, T. Xu, and N. Mittal Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain J Neurochem 77 2001 943 952 (Pubitemid 32466791)
79. J. Peng, M. Vigorito, X. Liu, D. Zhou, X. Wu, and S.L. Chang The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART J Neuroimmunol 218 2010 94 101
80. R.M. Post Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance Life Sci 26 1980 1275 1282 (Pubitemid 10048001)
81. P.M. Radcliffe, C.R. Sterling, and A.W. Tank Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone J Neurochem 109 2009 1272 1284
82. M.S. Reid, L.B. Ho, and S.P. Berger Behavioral and neurochemical components of nicotine sensitization following 15-day pretreatment: studies on contextual conditioning Behav Pharmacol 9 1998 137 148 (Pubitemid 28186510)
83. W. Reid, M. Sadowska, F. Denaro, S. Rao, J. Foulke Jr., and N. Hayes An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction Proc Natl Acad Sci USA 98 2001 9271 9276 (Pubitemid 32743906)
84. R.A. Rescorla Associative relations in instrumental learning - the 18th Bartlett Memorial Lecture Q J Exp Psychol B Comp Physiol Psychol 43 1991 1 23
85. D.C. Roberts, M.E. Corcoran, and H.C. Fibiger On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine Pharmacol Biochem Behav 6 1977 615 620 (Pubitemid 8147152)
86. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res Brain Res Rev 18 1993 247 291 (Pubitemid 23219500)
87. T.E. Robinson, and K.C. Berridge Addiction Annu Rev Psychol 54 2003 25 53 (Pubitemid 37417487)
88. S. Subramaniam, and K. Unsicker ERK and cell death: ERK1/2 in neuronal death FEBS J 277 2010 22 29
89. E. Thiels, B.I. Kanterewicz, E.D. Norman, J.M. Trzaskos, and E. Klann Long-term depression in the adult hippocampus in vivo involves activation of extracellular signal-regulated kinase and phosphorylation of Elk-1 J Neurosci 22 2002 2054 2062 (Pubitemid 35386506)
90. V.A. Triant, H. Lee, C. Hadigan, and S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506 2512 (Pubitemid 47037350)
91. E. Valjent, V. Pascoli, P. Svenningsson, S. Paul, H. Enslen, and J.C. Corvol Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum Proc Natl Acad Sci USA 102 2005 491 496 (Pubitemid 40116794)
92. E. Valjent, J.C. Corvol, J.M. Trzaskos, J.A. Girault, and D. Herve Role of the ERK pathway in psychostimulant-induced locomotor sensitization BMC Neurosci 7 2006 20
93. D.R. Wallace, S. Dodson, A. Nath, and R.M. Booze Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function Synapse 59 2006 51 60 (Pubitemid 41706154)
94. C.L. Walters, J.N. Cleck, Y.C. Kuo, and J.A. Blendy Mu-opioid receptor and CREB activation are required for nicotine reward Neuron 46 2005 933 943 (Pubitemid 40805353)
95. G.J. Wang, L. Chang, N.D. Volkow, F. Telang, J. Logan, and T. Ernst Decreased brain dopaminergic transporters in HIV-associated dementia patients Brain 127 2004 2452 2458 (Pubitemid 39472973)
96. K.M. Webb, M.Y. Aksenov, C.F. Mactutus, and R.M. Booze Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat J Neurovirol 16 2010 168 173
97. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol Rev 94 1987 469 492
98. S.W. Ying, M. Futter, K. Rosenblum, M.J. Webber, S.P. Hunt, and T.V. Bliss Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis J Neurosci 22 2002 1532 1540 (Pubitemid 35386272)
99. S. Yoon, and R. Seger The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions Growth Factors 24 2006 21 44 (Pubitemid 43108774)
100. L. Zhao, F. Li, Y. Zhang, N. Elbourkadi, Z. Wang, and C. Yu Mechanisms and genes involved in enhancement of HIV infectivity by tobacco smoke Toxicology 278 2010 242 248
101. 3H]2beta- carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes J Pharmacol Exp Ther 329 2009 1071 1083